From Performative to Participatory: The Rise of Mental Health Action Day On May 15, 2025, something unprecedented happened: more than...
Read moreA Pill That Dares to Outgrow Its Injection There are moments in drug development when a technical tweak—an extended-release coating...
Read moreThe future of health may already be sitting on your arm—small, circular, and constantly collecting data. Once a specialized tool...
Read moreIn the quiet margins of healthcare, menopause has long stood as a gaping omission. A ubiquitous biological transition that affects...
Read moreIn a healthcare landscape often defined by incremental change, few pharmaceuticals have sparked as much fervent demand—and ensuing controversy—as Ozempic...
Read moreAt gyms, cafes, and supermarket aisles, protein is king. We stir it into smoothies, sprinkle it on cereal, and chew...
Read moreIn 2007, the Human Microbiome Project began mapping the microbial terrain of the human body. At the time, the idea...
Read moreAt the microscopic heart of every human cell lies a biological paradox: mitochondria, the tiny energy generators that power life,...
Read moreIf you want to understand where healthcare is going, start by asking what people are Googling. That’s the philosophy behind...
Read moreIn a profession built on human connection, the growing embrace of artificial intelligence might seem counterintuitive. But when 81% of...
Read moreThe narrative around COVID-19 and children has long been shaped by a sense of guarded relief. While adults—particularly the elderly...
Read moreCardiologists and neurologists have long viewed atrial fibrillation (AFib) and dementia as two distinct clinical challenges. But a growing body...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy